Myeloid Cells and Innate Immunity in Solid Tumors
September 21-23, 2020 | 10:00AM EDT | 2:00PM UTC*
*Program is in development and subject to change
10:00am
- 10:30am EDT
- September 21, 2020
Judith A. Varner, PhD, Chair, University of California, San Diego
Track: Opening Remarks and Keynote Address
Monday
10:00am
- 10:30am EDT
- September 21, 2020
Robert H. Vonderheide, MD, PhD, University of Pennsylvania
Track: Keynote Address
10:30am
- 01:00pm EDT
- September 21, 2020
Judith A. Varner, PhD, Co-Chair, University of California, San Diego;
Dmitry I. Gabrilovich, MD, PhD, Co-Chair, AstraZeneca
Track: Ontogeny of Myeloid Cells in Cancer
Monday
10:30am
- 10:55am EDT
- September 21, 2020
Miriam Merad, MD, PhD, Mount Sinai School of Medicine
Track: Ontogeny of Myeloid Cells in Cancer
Monday
10:55am
- 11:20am EDT
- September 21, 2020
Track: Ontogeny of Myeloid Cells in Cancer
Monday
11:40am
- 12:05pm EDT
- September 21, 2020
David G. DeNardo, PhD, Washington University Medical School
Track: Ontogeny of Myeloid Cells in Cancer
Monday
12:05pm
- 12:30pm EDT
- September 21, 2020
Dmitry I. Gabrilovich, MD, PhD, AstraZeneca
Track: Ontogeny of Myeloid Cells in Cancer
Monday
12:30pm
- 12:45pm EDT
- September 21, 2020
Chang Su, Duke University
Track: Ontogeny of Myeloid Cells in Cancer
Monday
12:45pm
- 01:00pm EDT
- September 21, 2020
Danielle N. Huggins, PhD, University of Minnesota
Track: Ontogeny of Myeloid Cells in Cancer
05:00pm
- 08:00pm EDT
- September 21, 2020
Catherine Hedrick, PhD, Co-Chair, La Jolla Institute for Immunology;
Weiping Zou, MD, PhD, Co-Chair, University of Michigan
Track: Epigenetics, Metabolism and Metastasis of Myeloid Cells in Cancer
Monday
05:00pm
- 05:25pm EDT
- September 21, 2020
Gwendalyn J. Randolph, PhD, Washington University
Track: Epigenetics, Metabolism and Metastasis of Myeloid Cells in Cancer
Monday
05:25pm
- 05:50pm EDT
- September 21, 2020
Catherine Hedrick, PhD, La Jolla Institute for Immunology
Track: Epigenetics, Metabolism and Metastasis of Myeloid Cells in Cancer
Monday
05:50pm
- 06:15pm EDT
- September 21, 2020
Weiping Zou, MD, PhD, University of Michigan
Track: Epigenetics, Metabolism and Metastasis of Myeloid Cells in Cancer
Monday
06:40pm
- 07:05pm EDT
- September 21, 2020
Diana Hargreaves, PhD, The Salk Institute for Biological Studies
Track: Epigenetics, Metabolism and Metastasis of Myeloid Cells in Cancer
Monday
07:05pm
- 07:30pm EDT
- September 21, 2020
Florent Ginhoux, PhD, Singapore Immunology Network
Track: Epigenetics, Metabolism and Metastasis of Myeloid Cells in Cancer
Monday
07:30pm
- 07:45pm EDT
- September 21, 2020
Ferdinando Pucci, PhD, Oregon Health & Science University
Track: Epigenetics, Metabolism and Metastasis of Myeloid Cells in Cancer
Monday
07:45pm
- 08:00pm EDT
- September 21, 2020
Rachel Cederberg, BS, BC Cancer Research Centre
Track: Epigenetics, Metabolism and Metastasis of Myeloid Cells in Cancer
10:00am
- 01:00pm EDT
- September 22, 2020
Jeffrey W. Pollard, PhD, Co-Chair, Queen's Medical Research Institute;
Vincenzo Bronte, MD, Co-Chair, University of Verona
Track: Immune Suppression and Metastasis Mediated by Myeloid Cells
Tuesday
10:00am
- 10:25am EDT
- September 22, 2020
Jeffrey W. Pollard, PhD, Queen's Medical Research Institute
Track: Immune Suppression and Metastasis Mediated by Myeloid Cells
Tuesday
10:25am
- 10:50am EDT
- September 22, 2020
Jo A. Van Ginderachter, PhD, VIB-Vrije Universiteit Brussel
Track: Immune Suppression and Metastasis Mediated by Myeloid Cells
Tuesday
10:50am
- 11:15am EDT
- September 22, 2020
Vincenzo Bronte, MD, University of Verona
Track: Immune Suppression and Metastasis Mediated by Myeloid Cells
Tuesday
11:40am
- 12:05pm EDT
- September 22, 2020
Antonio Sica, PhD, University of Eastern Piedmont
Track: Immune Suppression and Metastasis Mediated by Myeloid Cells
Tuesday
12:05pm
- 12:30pm EDT
- September 22, 2020
Michael C. Schmid, PhD, University of Liverpool
Track: Immune Suppression and Metastasis Mediated by Myeloid Cells
Tuesday
12:30pm
- 12:45pm EDT
- September 22, 2020
Pierre Close, PhD, University of Liege
Track: Immune Suppression and Metastasis Mediated by Myeloid Cells
Tuesday
12:45pm
- 01:00pm EDT
- September 22, 2020
Hafsa Munir, PhD, University of Cambridge
Track: Immune Suppression and Metastasis Mediated by Myeloid Cells
Tuesday
02:30pm
- 03:30pm EDT
- September 22, 2020
Simon T. Barry, PhD, AstraZeneca;
Claudia Jakubzick, PhD, Dartmouth College;
Rosandra Natasha Kaplan, MD, NCI, National Institutes of Health
Track: Career Roundtable
Speaking at this Roundtable
Simon T. Barry, PhD, AstraZeneca
Claudia Jakubzick, PhD, Dartmouth College
Rosandra N. Kaplan, MD, NCI, National Institutes of Health
Event Date/Time: Tuesday, September 22, 2:30–3:30PM ET
As part of our commitment to support and train the next generation of scientific leaders from all backgrounds, Keystone Symposia hosts Career Roundtables at selected in-person and virtual conferences. These workshops create a forum for field leaders to provide their unique perspectives on career development, professional pitfalls and the breadth of scientific opportunities available to support trainee scientists. Established researchers are chosen from a broad range of backgrounds (i.e., diverse demographics, career stages and career paths) to reflect a myriad of career paths and experiences. A panel discussion is followed by break out group sessions to enable trainees to interact with each senior scientist in a comfortable small group setting, to address specific questions, allow for mentorship and networking.
For additional career advancement advice, see our Keypoint Blog "Words of Wisdom from Career Roundtables" with tips gleaned from past events on how to launch your career in academia, industry, publishing and beyond. Whether you are a student, post-doc, or early career investigator, check out these pearls of wisdom for all career stages!
05:00pm
- 08:00pm EDT
- September 22, 2020
Mikala Egeblad, PhD, Co-Chair, Cold Spring Harbor Laboratory;
Rosandra Natasha Kaplan, MD, Co-Chair, NCI, National Institutes of Health
Track: Promotion of Tumor Progression by Myeloid Cells
Tuesday
05:00pm
- 05:25pm EDT
- September 22, 2020
Mikala Egeblad, PhD, Cold Spring Harbor Laboratory
Track: Promotion of Tumor Progression by Myeloid Cells
Tuesday
05:25pm
- 05:50pm EDT
- September 22, 2020
Minna Roh-Johnson, PhD, University of Utah
Track: Promotion of Tumor Progression by Myeloid Cells
Tuesday
05:50pm
- 06:15pm EDT
- September 22, 2020
Claudia Jakubzick, PhD, Dartmouth College
Track: Promotion of Tumor Progression by Myeloid Cells
Tuesday
06:40pm
- 07:05pm EDT
- September 22, 2020
Shruti Naik, PhD, New York University
Track: Promotion of Tumor Progression by Myeloid Cells
Tuesday
07:05pm
- 07:30pm EDT
- September 22, 2020
Rosandra Natasha Kaplan, MD, NCI, National Institutes of Health
Track: Promotion of Tumor Progression by Myeloid Cells
Tuesday
07:30pm
- 07:45pm EDT
- September 22, 2020
Mingjian Fei, Genentech
Track: Promotion of Tumor Progression by Myeloid Cells
Tuesday
07:45pm
- 08:00pm EDT
- September 22, 2020
Ziyan Zoe Xu, BS, The Salk Institute
Track: Promotion of Tumor Progression by Myeloid Cells
10:00am
- 01:00pm EDT
- September 23, 2020
Lisa M. Coussens, PhD, Co-Chair, Oregon Health & Science University;
Simon T. Barry, PhD, Co-Chair, AstraZeneca
Track: Targeting Myeloid Cells in Cancer Therapy I
Wednesday
10:00am
- 10:25am EDT
- September 23, 2020
Lisa M. Coussens, PhD, Oregon Health & Science University
Track: Targeting Myeloid Cells in Cancer Therapy I
Wednesday
10:25am
- 10:50am EDT
- September 23, 2020
Limin Shang, PhD, Light Chain Bioscience
Track: Targeting Myeloid Cells in Cancer Therapy I
Wednesday
10:50am
- 11:15am EDT
- September 23, 2020
Simon T. Barry, PhD, AstraZeneca
Track: Targeting Myeloid Cells in Cancer Therapy I
Wednesday
11:40am
- 12:05pm EDT
- September 23, 2020
Nagy A. Habib, MD, PhD, Imperial College London and MiNA Therapeutics
Track: Targeting Myeloid Cells in Cancer Therapy I
Wednesday
12:05pm
- 12:20pm EDT
- September 23, 2020
Sven Brandau, PhD, University Hospital Essen
Track: Targeting Myeloid Cells in Cancer Therapy I
Wednesday
12:20pm
- 12:35pm EDT
- September 23, 2020
Yolanda Calle, PhD, University of Roehampton
Track: Targeting Myeloid Cells in Cancer Therapy I
Wednesday
12:35pm
- 12:50pm EDT
- September 23, 2020
Natalie Horvat, MSc, European Molecular Biological Laboratories
Track: Targeting Myeloid Cells in Cancer Therapy I
05:00pm
- 08:00pm EDT
- September 23, 2020
Jennifer Guerriero, PhD, Co-Chair, Dana-Farber Cancer Institute;
David A. Cheresh, PhD, Co-Chair, University of California, San Diego
Track: Targeting Myeloid Cells in Cancer Therapy II
Wednesday
05:00pm
- 05:25pm EDT
- September 23, 2020
Brenda C. O'Connell, PhD, Infinity Pharmaceuticals, Inc
Track: Targeting Myeloid Cells in Cancer Therapy II
Wednesday
05:25pm
- 05:50pm EDT
- September 23, 2020
Jennifer Guerriero, PhD, Dana-Farber Cancer Institute
Track: Targeting Myeloid Cells in Cancer Therapy II
Wednesday
05:50pm
- 06:15pm EDT
- September 23, 2020
David A. Cheresh, PhD, University of California, San Diego
Track: Targeting Myeloid Cells in Cancer Therapy II
Wednesday
06:40pm
- 06:55pm EDT
- September 23, 2020
Caroline Bonnans, Immune-Onc Therapeutics
Track: Targeting Myeloid Cells in Cancer Therapy II
Wednesday
06:55pm
- 07:10pm EDT
- September 23, 2020
Shadi Swaidani, PhD, Cleveland Clinic Foundation
Track: Targeting Myeloid Cells in Cancer Therapy II
Wednesday
07:10pm
- 07:25pm EDT
- September 23, 2020
Mehdi Chaib, M.S., University of Tennessee Health Science Center
Track: Targeting Myeloid Cells in Cancer Therapy II
Wednesday
07:25pm
- 07:40pm EDT
- September 23, 2020
Jihong Bae, M.S., Korea Advanced Institute of Science and Technology
Track: Targeting Myeloid Cells in Cancer Therapy II